Juvenile Myoclonic Epilepsy Testing in Rhodesian Ridgebacks

Rhodesian Ridgebacks are particularly susceptible to Juvenile Myoclonic Epilepsy (JME), an inherited neurological condition primarily affecting young dogs, often starting around six months of age. This form of epilepsy is distinct as it tends to begin early in life with frequent myoclonic seizures—sudden, involuntary muscle jerks or twitches—that commonly occur during rest or sleep.

Unlike other types of epilepsy that tend to appear later in life, JME develops early and can considerably affect a dog's quality of life if not managed properly.

Understanding Juvenile Myoclonic Epilepsy

JME is a genetic epilepsy characterized by brief, involuntary muscle spasms and jerky movements. These seizures can happen unpredictably, frequently during periods of rest or sleep, and may also be triggered by bright lights or other environmental stimuli. Dogs with JME can experience high seizure frequency, sometimes exceeding 100 episodes daily, requiring diligent supervision to ensure their safety during these events.

Who Is At Risk?

This condition is predominantly seen in Rhodesian Ridgebacks, with research in the U.S. estimating that around 15% of the breed may carry the gene mutation linked to JME. Symptoms typically emerge from a few weeks up to 18 months. Dogs older than two years without symptoms are usually not affected but can still be carriers.

Genetic Inheritance of JME

JME follows an autosomal recessive inheritance pattern, meaning a dog must inherit two copies of the defective gene—one from each parent—to develop the condition. Dogs with only one copy are carriers; they generally show no symptoms but can pass the mutation to their offspring. Awareness of this inheritance helps breeders avoid mating two carriers, reducing affected puppies in the population.

• Two clear parents: All puppies are free of the mutation.
• Two affected parents: All puppies inherit the condition.
• Two carriers: Approximately 25% of puppies affected, 50% carriers, and 25% clear.
• One clear and one affected parent: All puppies are carriers but not affected.
• One carrier and one clear parent: Approximately 50% carriers, 50% clear puppies.
• One carrier and one affected parent: Around 50% affected, 50% carriers.

Importance of Genetic Testing

The only way to confidently determine a dog's genetic status for JME is through DNA testing. A veterinarian collects a cheek swab or blood sample, which is sent to specialized laboratories offering tests with results generally returned within a few days to a few weeks. Test outcomes classify dogs as clear, carrier, or affected.

In the U.S., reputable breeders routinely perform these genetic tests on their breeding dogs to responsibly avoid producing affected puppies. Carrier-to-carrier matings are typically avoided due to the high risk of affected offspring; however, breeding carriers to clear dogs is sometimes accepted to maintain genetic diversity, provided offspring are tested before breeding.

Buying and Breeding Healthy Rhodesian Ridgebacks

When looking for a Rhodesian Ridgeback puppy, always seek breeders who provide documented proof of genetic testing for JME. Avoid those who do not test, as unaware breeding of carriers and affected dogs perpetuates the disease in the breed.

Genetic screening empowers breeders and owners to make informed choices, ultimately enhancing the health and welfare of Rhodesian Ridgebacks nationwide.